Megan Brooks

Researchers have identified novel retinal vascular signatures that are significantly associated with the risk for a first stroke.

The US Food and Drug Administration (FDA) has approved a supplemental new drug application allowing esketamine nasal spray (Spravato; Johnson & Johnson) to

Adding the somatostatin analog lanreotide to the mTOR inhibitor everolimus significantly prolonged progression-free survival in patients with

Heart disease remains the leading cause of death in the United States, fueled by ongoing increases in hypertension, obesity, and other major risk

Low-dose aspirin reduced colorectal cancer (CRC) recurrence rates by more than half in patients with tumors harboring mutations in the PI3K signaling pathway, according to findings from the phase 3 ALASCCA trial.

Overtreatment of men with prostate cancer and limited life expectancy (LE) has persisted in the era of active surveillance and worsened in some instances, according to a new study of nearly 250,000 veterans.

About a year ago, the US Food and Drug Administration (FDA) granted premarket approval to AvertD (SOLVD Health), the first genetic test to assess an individual's risk of developing opioid use disorder (OUD).

A new study released this week adds to mounting evidence that suggests climate change, with extreme hot and cold temperatures, threatens not only physical health but also mental well-being.

Rollout of the 988 suicide and crisis hotline in the United States has not led to significant and equitable growth in the availability of most mental

For most patients with clinical stage I-II deficient mismatch repair (dMMR) colon cancer, a single cycle of neoadjuvant pembrolizumab may be sufficient